Perindopril/indapamide

Drug Profile

Perindopril/indapamide

Alternative Names: Biprel; Coversyl Arginine Plus; Coversyl Plus; DW 7950; Indapamide/perindopril; Perigard-D; perindopril + indapamide; Predonium; Predonium DS; Preterax; S 5590

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Servier
  • Class Antihypertensives; Indoles; Sulfonamides
  • Mechanism of Action ACE inhibitors; Diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 19 Jun 2008 Efficacy data from a Phase-III trial (ADVANCE) in Hypertension presented at the 18th European Meeting on Hypertension (ESH-2008)
  • 17 Oct 2006 CV Therapeutics has terminated its licence for perindopril/indapamide in the US
  • 31 Mar 2006 Launched for Hypertension in New Zealand (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top